2026³â 05¿ù 18ÀÏ ¿ù¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

IQOS and Devialet Introduce ¡°Soundsorial Design¡± Collaboration

Exhibition and capsule collection drop at Milan Design Week 2026
´º½ºÀÏÀÚ: 2026-05-18

STAMFORD, CT -- Philip Morris International (NYSE: PM) today announced a collaboration between IQOS - the number 1 tobacco heating system[1], and Devialet - the French acoustic engineering company, launching “Soundsorial Design” at Milan Design Week 2026.

The immersive exhibition is an ethereal landscape of water and light, where sound, movement, and voice become visible across an ever‑changing immersive canvas. A space to push experiential boundaries, where visitors are invited to explore their own frequency as sound transforms into sight. The collaboration celebrates self-expression while connecting a community of over 35 million IQOS users who moved away from cigarettes.

Devialet’s mission to give sound its rightful place in our lives, achieved through acoustic breakthroughs, meets IQOS’s bold spirit of being forever curious - the force that pushes the brand to continuously innovate and explore new technologies for a better future. Two precision cultures, one pursuit of excellence.

“In both houses, design is deeply functional and innovation is the foundation. Patents, products and peer standards are the evidence. United by a relentless commitment to push innovation boundaries, Devialet and IQOS’ collaboration challenges the status quo while redefining the experiences of tomorrow,” said Oggie Kapetanovic, President Heat Not Burn, Philip Morris International.

Brought to life through innovative technology, the ‘Soundsorial Design’ exhibition becomes a space to push experiential boundaries - where Devialet’s sound is alive: seen through the movement of its iconic woofers and felt physically through its powerful infrabass - inviting us to explore until we find our own frequency and witness the moment when immersive sound transforms into sight.

“Driven by a shared ambition to disrupt industry conventions, IQOS and Devialet have designed a truly ‘soundsorial’ experience for this exhibition. By bringing Devialet’s savoir-faire to the space, we have ensured that sound is no longer just a backdrop—it becomes a physical presence that completes the journey, embodied by the iconic design and performance of the Devialet Phantom Ultimate speaker”, emphasized Jacques Demont, Devialet’s Chief Executive Officer.

Also unveiled as part of the collaboration is the ‘Soundsorial’ Limited-Edition Capsule Drop. The unique piece by IQOS and Devialet is a creation born from the collaboration between the two brands, crafted for those who seek an exceptional union. The exclusive set pairs the IQOS ILUMA i PRIME with Devialet’s Gemini II earbuds, featuring sound-wave-inspired patterns.

“The sound waves carry a signature rhythm - a pattern as unique as a fingerprint. Yet waves also belong to the collective, they are energy moving through space, the invisible currents that bind us to one another. This duality mirrors the spirit of the IQOS and Devialet collaboration. Devialet’s sound waves turn emotion into shared experience; IQOS empowers self‑expression while connecting a community of over 35 million users[2]”, concluded Oggie Kapetanovic.

‘IQOS X Devialet: Soundsorial Design’ will be staged at Opificio 31, inside Tortona Rocks, from April 20 to 27 2026, from 10:00 to 21:00 CEST each day.

IMPORTANT INFORMATION: IQOS is not risk-free and provides nicotine, which is addictive.

Philip Morris International: A Global Smoke-Free Champion

Philip Morris International is a leading international consumer goods company, actively delivering a smoke-free future and evolving its portfolio for the long term to include products outside of the tobacco and nicotine sector. The company’s current product portfolio primarily consists of cigarettes and smokefree products, including heat-not-burn, nicotine pouch and e-vapor products. Our smoke-free products are available for sale in over 105 markets, and as of December 31, 2025 PMI estimates they were used by over 43 million legal-age consumers around the world, many of whom have moved away from cigarettes or significantly reduced their consumption. The smoke-free business accounted for 41.5% of PMI’s full year 2025 total net revenues. Since 2008, PMI has invested over $16 billion to develop, scientifically substantiate and commercialize innovative smoke-free products for adults who would otherwise continue to smoke, with the goal of completely ending the sale of cigarettes. This includes the building of worldclass scientific assessment capabilities, notably in the areas of pre-clinical systems toxicology, clinical and behavioral research, as well as post-market studies. Following a robust science-based review, the U.S. Food and Drug Administration has authorized the marketing of Swedish Match’s General snus and ZYN nicotine pouches and versions of PMI’s IQOS devices and consumables - the first-ever such authorizations in their respective categories. Versions of IQOS devices and consumables and General snus also obtained the first-ever Modified Risk Tobacco Product authorizations from the FDA. With a strong foundation and significant expertise in life sciences, PMI has a long-term ambition to expand into wellness areas. References to “PMI”, “we”, “our” and “us” mean Philip Morris International Inc., and its subsidiaries.



 Àüü´º½º¸ñ·ÏÀ¸·Î

Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program
IQOS and Devialet Introduce ¡°Soundsorial Design¡± Collaboration
Global Smartphone Shipments Exceed Expectations With 1% Growth in 1Q26
Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate Candidate
Nexthop AI Unveils Scale-Out and Scale-Across Switches for Hyperscalers and NeoClouds, Driving Transformative Growth
Sia Hits Milestone: Over 800 AI Agents Now Available in Agent Store, Marking Shift From Ambition to Applied Intelligence
Guidewire Launches ProNavigator, Embedding Expert AI Insights into Insurance Workflows

 

Toshiba Starts Sample Shipments of New ¡°SmartMCD¢â¡± Series Product I...
Firms in Asia Pacific Use ServiceNow to Build AI Operations
ASC26 Student Supercomputer Challenge Finals Set to Begin: Five Highli...
IFF Expands Latin American Footprint With New Enzyme Hub, Brazil Appli...
Faraday Delivers IP Solutions to Enable Endpoint AI Based on UMC¡¯s 28...
Galderma Debuts Alastin Regenerating Skin Nectar With TriHex+, Advanci...
TestMu AI and Quarks Technosoft Partner to Power the Next Era of Auton...

 


°øÁö»çÇ×
'º£³×ÀÍ' Áß¹® Ç¥±â 宝Ò¬ìÌ, 'À̺ñÁî: ÀÌÁö' Áß¹® Ç¥±â æ¶币òª...
¿¡³ÊÀÌÀ¯ EnerEU 额Òö äþÒö
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´º½ºÁö Áß¹®Ç¥±â´Â À½Â÷ Ç¥±â¹æ½Ä '纽ÞÙó¢ ´Ï¿ì½ºÁö'
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®À¯ºñ Alliuv ä¹备: ä¹êó备, ¾Ë¶ã Althle ä¹÷åìÌ
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØ ä¹ì³ÜØ
´º½º±×·ì Á¤º¸ ¹Ìµð¾î ºÎ¹® »óÇ¥µî·Ï
¾ËÇÁ·Ò °è¿­ »óÇ¥, »óÇ¥µî·Ï ¿Ï·á

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..